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Abstract
Detection of circulating influenza strains is a key public health concern especially in limited-resource settings where
diagnosis capabilities remain a challenge. As part of multi-site surveillance in Côte d’Ivoire during the 2009 influenza A(H1N1)
pandemic, we had the opportunity to test respiratory specimens collected from patients with acute respiratory illness (ARI). We
analyzed and compared the percentage of specimens testing positive using three laboratory methods (rtRT-PCR, ELISA, viral
culture). From January to October 2009, 1,356 respiratory specimens were collected from patients with acute respiratory illness
and shipped at the WHO NIC (Institut Pasteur) Cote d’Ivoire, and 453 (33%) tested positive for influenza by one or more
laboratory methods. The proportion of positive influenza tests did not differ by the sex or age of the patient or presenting
symptoms, but did differ depending on the timing and site of specimen collection. Of the 453 positive specimens, 424 (93.6%)
were detected by PCR, 199 (43.9%) by ELISA and 40 (8.8%) by viral culture. While seasonal influenza A(H1N1) virus strains
were prominent, only four 2009 pandemic influenza A(H1N1) cases were detected. Use of molecular biology method (rtRT-
PCR) increased sensitivity and diagnosis capabilities. Among all three methods used, rRT-PCR was the most sensitive and rapid
method. More capacity building is still required for viral culture. Need to collect denominator data in order to have an accurate
estimate of the burden of influenza. There was delayed introduction of pandemic influenza A(H1N1)2009 in Cote d’Ivoire
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Introduction
The relatively recent introduction of influenza surveillance and laboratory-based confirmation of influenza in Africa has
expanded understanding of the burden of influenza in previously overlooked regions of the world (Gressner et al., 2011). As part
of multi-site surveillance in Côte d’Ivoire during the 2009 influenza A(H1N1) pandemic, we had the opportunity to test
respiratory specimens collected from patients with acute respiratory illness (ARI) using three laboratory methods. This allowed us
to replicate analyses conducted in previous studies in the United States (Grody et al., 2009) and Europe (Quinlivan et al., 2004;
Steininger et al., 2002), compare the percentage of specimens testing positive using three laboratory methods. The timing of the
surveillance from January 1 to October 31, 2009 also allowed us to identify the types and subtypes of locally circulating influenza
during a period when 2009 pandemic A(H1N1) was widespread throughout other parts of the world.
Methods
Setting and Population: As part of local monitoring of the 2009 influenza A(H1N1) pandemic, respiratory specimens were
collected from January 1 to October 31, 2009 from 18 surveillance sites, which included 10 existing surveillance sites and 8
health facilities serving urban areas in Côte d’Ivoire. Most sites served outpatients only, though three in Abidjan (Treichville,
Cocody, and Yopougon) were hospital settings. Patients that presented at the surveillance sites with symptoms of acute respiratory
infection (ARI) were screened. In the outpatient settings, if the patient met WHO case definition for influenza-like-illness (ILI)
(temperature ≥ 38.0°C and either cough or sore throat) they were enrolled. Hospitalized patients were enrolled if they met criteria 
for severe acute respiratory infection (SARI) (which for the age range 2 months to 4 years includes cough or shortness of breath
or difficulty breathing and any sign of severe illness; for those age 5 years and older symptoms include temperature ≥ 38.0°C and 
cough with shortness of breath or difficulty breathing). Patient information, symptom reports, and days since onset were recorded
using a standardized surveillance questionnaire.
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Human Use Statement: The protocol for this study did not require approval neither from the Cote d’Ivoire Ministry of Health
nor the U. S. Naval Medical Research Unit No. 3 Institutional Review Board; simply because this activity was considered as a
routine surveillance activity and not research. However, it was conducted in compliance with all applicable Federal regulations
governing the protection of human subjects.
Respiratory Specimens: Whole respiratory specimens collected with nasal pharyngeal (NP) swabs at the outpatient department
for ILI and at the hospitalization ward for SARI patients were stored in Viral Transportation Medium (VTM) at + 4°C in a
refrigerator at the laboratory of the sentinel site. Twice a week (Wednesdays and Fridays) collected specimens were shipped in
cool boxes containing cold-packs to the WHO National Influenza Center located at the Institut Pasteur of Côte d’Ivoire along with
the completed questionnaires. Dates of illness onset and specimen collection were recorded. Specimens were accepted up to 14
days after illness onset.
Influenza Testing: Three methods of influenza detection were used to confirm the diagnosis: (a) real time reverse transcription
polymerase chain reaction (rRT-PCR) assay, (b) enzyme-linked immunosorbent assay (ELISA) and (c) viral culture. Influenza
typing and subtyping were performed with rRT-PCR using the automated ABI 7300 for the detection of M genes and
hemagglutinin proteins (H1, H3 and pandemic H1) using CDC developed primers and probes. ELISA antigen detection of
influenza A and B was performed using monoclonal and polyclonal antibodies of immunized rabbits. Viral culture was performed
using Madin-Darby Canine Kidney (MDCK) cells.
For each specimen that was collected, 3 aliquots were made; the first (500 microliters) was used for both rRT-PCR (140
microliters) & ELISA (200 microliters), the second (500 microliters) was used for viral culture and the last was stored at -80 °C.
Testing was done in parallel for each specimen using ELISA and rRT-PCR techniques and, only influenza positive specimens
with any of the 2 methods were cultured.
Analysis: Proportions positive by any of the three methods and by each method separately were compared by gender, age, illness
symptoms, clinical diagnosis, and days elapsed since illness onset. Proportions were also compared between seven large
surveillance sites (with ≥ 40 specimens collected) and between the capital district (Abidjan) and the interior country districts 
(Adzope, Agnibilekro, Akoupe, and Bouake). Chi-square tests were conducted to test the significance of differences in the
distribution of positive results between patient groups and the distribution of types and subtypes identified by rRT-PCR. Kappa
tests of association were used to quantify the agreement between testing methods using STATA version 11.0 (STATA
Corporation Texas, USA).
Results
From January 1 to October 31, 2009, respiratory specimens were collected from 1,356 patients with ARI in Côte
d’Ivoire. As listed in Table 1, about half of the ARI patients were male (55%) and under age 19 (56%).
Of 1,356 patients, 453 (33%) ARI patients had laboratory-confirmed influenza by one or more of the three detection
assays. Influenza positivity proportions did not differ significantly across age groups, but ranged from 30% among patients age 40
to 54 years to 38% among patients age 5 to 19 years. Positivity proportions were similar for those clinically diagnosed with ILI
(39%) and SARI (42%) and similar for those presenting with fever (32%), cough (33%), or sore throat (34%). However, patients
who had one or more ARI symptoms, but did not have a clinical diagnosis in their charts, had significantly fewer positive
specimens (14%).
The most substantial variation in influenza positivity was associated with the time elapsed between illness onset and
specimen collection. The proportion of specimens testing positive for influenza by any method was highest among specimens
collected within 5 days of illness onset (74%) and lowest among specimens collected 6 or more days after illness onset (7%). The
mean number of days from specimen collection to delivery at the reference laboratory was 1.3 days (standard deviation (SD) =
1.8) within the capital district and approximately 3.9 days (SD = 2.8) in the interior districts.
Statistically significant differences in the proportion of respiratory specimens testing influenza positive by any method
were noted between the seven large surveillance sites, which varied from 20% among specimens collected at the United Nations
Mission in Côte d’Ivoire (ONUCI) to 42% among specimens from Adzope General Hospital. Laboratory-confirmed influenza was
also higher among specimens collected from interior districts of the country (40%) compared to the large capital district, Abidjan
(32%).
As expected, there was strong and statistically significant agreement across methods. Agreement between rRT-PCR and
ELISA results was especially high (Kappa = 0.43; z = 17.4, p < .001). Nevertheless, rRT-PCR was the most sensitive method.
rRT-PCR detected 225 cases (or 17% of the study population) that were not detected by ELISA and 384 cases (28% of the study
population) not detected by viral culture.
The majority of influenza viruses were influenza type A, with H3N2 the most commonly detected sub-type. During this
pandemic period, we detected seasonal influenza A(H1N1) virus strains, but less than 1% of specimens were 2009 pandemic
influenza A(H1N1). Types and subtypes of influenza virus strains detected by rRT-PCR did not differ significantly by age group,
district or site, or by clinical diagnosis (ILI, SARI).
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Table 1: Descriptive characteristics and proportions of influenza positive specimens by method of assay among 1356 patients in
Côte d’Ivoire from January 1 to October 31, 2009.
Total N
(%)
N (% of all
tested
specimens)
Positivity
by any
method
N (% of all
positive
tests) RT-
PCR
Confirmed
N (% of all
positive
tests)
ELISA
Confirmed
N (% of all
positive
tests) Viral
Culture
Confirmed
All 1356 (100) 453 (33.4) 424 (93.6) 199 (43.9) 40 (8.8)
Influenza type and
subtype
A(H1N1) seasonal - - 28 (6.6) - -
A(H1N1) pandemic - - 4 (0.9) - -
A(H3N2) - - 169 (39.9) - -
A (unsubtypable) - - 115 (27.1) - -
B - - 108 (25.5) - -
Gender
Male 740 (54.6) 235 (31.8) 223 (94.9) 107 (45.5) 24 (10.2)
Female 580 (42.8) 203 (35.0) 189 (93.1) 83 (40.9) 13 (6.4)
Not classified 36 (2.6) - - - -
Age
0-4 years 592 (43.7) 204 (34.5) 192 (94.1) 87 (42.7) 15 (7.4)
5-19 years 166 (12.2) 63 (38.0) 61 (96.8) 26 (41.3) 9 (14.3)
20-39 years 405 (29.9) 126 (31.1) 113 (89.7) 65 (51.6) 12 (9.5)
40-54 years 111 (8.2) 33 (29.7) 32 (97.0) 9 (27.3) 1 (3.0)
55+ 36 (2.7) 13 (36.1) 13 (100.0) 6 (46.2) 1 (7.7)
Unknown 46 (3.4) - - - -
Illness/Symptoms
Fever 1060(78.2) 342 (32.3) 319 (93.3) 151 (44.2) 28 (8.2)
Cough 963 (76.4) 322 (33.4) 304 (94.4) 131 (40.7) 28 (8.7)
Sore throat 181 (13.4) 62 (34.3) 59 (95.2) 31 (50.0) 8 (12.9)
Clinical recorded
diagnoses
ILI among
outpatients
1017(75.0) 398 (39.1) 380 (95.5) 175 (44.0) 34 (8.5)
SARI among
inpatients
24 (1.8) 10 (41.7) 8 (80.0) 5 (50.0) 3 (30.0)
Not classified 315 (23.2) 45 (14.3) 36 (80.0) 19 (42.2) 3 (6.7)
Days since onset
when specimen
collected
0-3 days 832 (61.4) 288 (34.6) 274 (95.1) 129 (44.8) 31 (10.8)
4-5 days 128 (9.4) 46 (35.9) 43 (93.5) 18 (39.1) 3 (6.5)
6-7 days 89 (6.6) 20 (22.5) 16 (80.0) 7 (35.5) 2 (10.0)
8+ days 52 (3.8) 13 (25) 12 (92.3) 6 (46.1) 0 (0.0)
Unknown 255 (18.8) - - - -
Large surveillance
sites
AGEFOSYN 205 (15.1) 47 (22.9) 41 (87.2) 18 (38.3) 1 (2.1)
ATTECOUBE 521 (38.5) 186 (35.7) 178 (95.7) 80 (43.0) 17 (9.1)
M.A.C.A 198 (14.6) 55 (27.8) 49 (89.1) 30 (54.6) 2 (3.6)
ADZOPE 45 (3.3) 19 (42.2) 18 (94.7) 11 (57.9) 2 (10.5)
AGNIBILEKRO 103 (7.6) 41 (39.8) 39 (95.1) 17 (41.5) 4 (9.8)
INHP 43 (3.2) 18 (41.9) 18 (100.0) 5 (27.8) 1 (5.6)
U.N. Mission CI 55 (4.1) 11 (20.0) 11 (100.0) 5 (45.5) 2 (18.2)
Large districts
ABIDJAN district 1097(80.9) 345 (31.5) 322 (93.3) 148 (42.9) 29 (8.4)
INTERIOR districts 212 (15.6) 85 (40.1) 80 (94.1) 40 (47.1) 8 (9.4)
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Discussion
About 1 in 3 patients with ARI had laboratory-confirmed influenza. This prevalence, which is similar to or higher than,
estimates of influenza infection incidence in the United States (Brammer et al., 2002), other western countries (Terletskaia-
Ladwig et al., 2009), and Asia (Simmerman et al., 2008) reaffirms influenza virus infection is a prominent cause of ARI in Côte
d’Ivoire. Surprisingly, seasonal influenza strains predominated in this region during a time when 2009 pandemic A(H1N1) was
widespread in other parts of the world.
Positivity proportions using any of the three diagnostic methods pointed to similar rates of influenza across age and
gender groups. Contrary to expectations, positivity rates were not higher among young children in Côte d’Ivoire, neither for
hospitalized nor for non-hospitalized children. Findings in hospitalized children in the U.S. (Dawood et al., 2010) also showed
low positivity rates.
The influenza positivity rates were higher among specimens collected within 5 days of illness onset, which fits with
other surveillance findings (Belongia et al., 2009).
We also noted significant differences in influenza positivity rates across surveillance sites. This may reflect differences
in local screening practices. Lacking a denominator for all ARI patients at each surveillance site limits our ability to interpret
these differences.
A higher incidence of influenza in the interior region was noted despite transportation delays and other specimen
management issues that may have reduced detection among these specimens.
Although there was high agreement between the laboratory methods, rRT-PCR was the most sensitive influenza
diagnostic method. ELISA missed 1 in 5 influenza cases, and viral culture missed 1 in 4 influenza cases, compared with rRT-
PCR. Given that rRT-PCR takes hours to complete versus days for viral culture, it also has advantages in feasibility and
timeliness. Although viral culture will continue to play a key laboratory role (e.g., for isolate characterization), expanding rRT-
PCR capacity in Africa could increase the number of appropriately diagnosed patients and expand our understanding of the
epidemiology of influenza.
Conclusion
Seasonal influenza strains were a prominent cause of ARI in western Africa during the 2009 pandemic and were the
predominant circulating strain in Côte d’Ivoire through October, 2009 while pandemic influenza A(H1N1) was the predominant
circulating strain in most parts of the world. rRT-PCR proved to be the most sensitive method of detection, which reinforces the
importance of expanding rRT-PCR capacity in Africa where laboratory diagnosis of diseases with epidemic and pandemic
potential is especially important.
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